Atossa Therapeutics
ATOS
ATOS
73 hedge funds and large institutions have $25M invested in Atossa Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 33 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less capital invested
Capital invested by funds: $45.4M → $25M (-$20.4M)
79% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 33
Holders
73
Holding in Top 10
–
Calls
$1.92M
Puts
$2.05M
Top Buyers
| 1 | +$2.43M | |
| 2 | +$1.67M | |
| 3 | +$561K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$177K |
| 5 |
Morgan Stanley
New York
|
+$130K |
Top Sellers
| 1 | -$6.38M | |
| 2 | -$3.18M | |
| 3 | -$1.91M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.73M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.1M |